Why the study?
Additional supportive evidence was needed to evaluate non-inferiority in efficacy and superiority in safety of percutaneous mitral valve repair using MitraClip versus conventional surgery in high-risk patients.
Key points are not available for this paper at this time.
Population
Patients with severe primary mitral regurgitation eligible for high-risk surgery
Comparison
Percutaneous mitral valve repair using the MitraClip vs conventional surgery
Design
Randomised study
Answers are grounded in this paper and cite their sources.
The randomised MITRA-HR study is designed to provide additional supportive evidence of non-inferiority in efficacy and superiority in safety for percutaneous mitral valve repair using the MitraClip compared to conventional surgery in high surgical risk patients.
No takes yet. Share an insight, caveat, or question.
Piriou et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: